消除METTL1介导的PMN-MDSC积聚可预防射频消融后肝细胞癌复发
研究探讨METTL1在射频消融不全(iRFA)后免疫抑制微环境中的作用。结果显示METTL1通过增强TGF-β2翻译促进PMN-MDSC积聚并减少CD8+ T细胞,阻断METTL1-TGF-β2-PMN-MDSC轴可恢复抗肿瘤免疫并预防HCC复发。
要点
- RFA后复发性HCC中METTL1表达增强,伴PMN-MDSC增多和CD8+ T细胞减少。
- 热介导的METTL1上调通过增强TGF-β2翻译诱导免疫抑制环境。
- 阻断METTL1-TGF-β2-PMN-MDSC轴可恢复CD8+ T细胞并抑制iRFA诱导的肿瘤进展。
核心结论
- METTL1在调节免疫抑制微环境中起关键作用,阻断METTL1-TGF-β2-PMN-MDSC轴可能成为恢复抗肿瘤免疫和预防RFA后HCC复发的治疗策略,值得进一步临床研究。
研究设计与样本
- 研究采用免疫组织化学和多色免疫荧光(mIF)染色,并结合小鼠模型进行肝特异性Mettl1过表达或敲低实验。
主要发现
- RFA后复发性HCC中METTL1表达增强,伴CD11b+CD15+ PMN-MDSC增多和CD8+ T细胞减少。
- 热介导的METTL1上调增强TGF-β2翻译,通过诱导髓源性抑制细胞形成免疫抑制环境。
- 与假手术相比,iRFA处理小鼠肿瘤生长和转移增强,PMN-MDSC积聚增加,CD8+ T细胞减少。
- 通过抗Ly6G抗体、敲低肝癌内在Mettl1或Tgfb2、或阻断TGF-β信号,可显著减轻iRFA诱导的肿瘤进展并恢复CD8+ T细胞群。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Radiofrequency ablation (RFA) is an important curative therapy in hepatocellular carcinoma (HCC), but recurrence rate remains as high as all the other HCC therapeutic modalities. Methyltransferase 1 (METTL1), an enzyme for m 7 G tRNA modification, was reported to promote HCC development. Here, we assessed the role of METTL1 in shaping the immunosuppressive tumor microenvironment after insufficient RFA (iRFA). APPROACH AND RESULTS: By immunohistochemistry and multiplex immunofluorescence (mIF) staining, we showed that METTL1 expression was enhanced in post-RFA recurrent HCC, accompanied by increased CD11b + CD15 + polymorphonuclear-myeloid-derived suppressor cells (PMN-MDSCs) and decreased CD8 + T cells. Mechanistically, heat-mediated METTL1 upregulation enhanced TGF-β2 translation to form the immunosuppressive environment by induction of myeloid-derived suppressor cell. Liver-specific overexpression or knockdown of Mettl1 significantly affected the accumulation of PMN-MDSCs and subsequently affected CD8 + T cell infiltration. Complete RFA successfully eliminated the tumor, whereas iRFA-treated mice exhibited enhanced tumor growth and metastasis with increased PMN-MDSC accumulation and decreased CD8 + T cells compared to sham surgery. Interrupting METTL1-TGF-β2-PMN-MDSC axis by anti-Ly6G antibody, or knockdown of hepatoma-intrinsic Mettl1 or Tgfb2 , or TGF-β signaling blockade significantly mitigated tumor progression induced by iRFA and restored CD8 + T cell population. CONCLUSIONS: Our study sheds light on the pivotal role of METTL1 in modulating an immunosuppressive microenvironment and demonstrated that interrupting METTL1-TGF-β2-PMN-MDSC axis could be a therapeutic strategy to restore antitumor immunity and prevent HCC recurrence after RFA treatment, meriting further clinical studies.
引用
- Zeng X, Liao G, Li S, et al. Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology. 2022. PMID: 35598182. doi:10.1002/hep.32585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。